Extending the sensitivity and accuracy of molecular diagnostics

提高分子诊断的灵敏度和准确性

• 批准号: 499957-2016
• 负责人: Milstein, Joshua
• 金额: $ 0.91万
• 依托单位: University of Toronto
• 依托单位国家: 加拿大
• 项目类别: Engage Plus Grants Program
• 财政年份: 2016
• 资助国家: 加拿大
• 起止时间: 2016-01-01 至 2017-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=607797
• 关键词: Extending; sensitivity; accuracy; molecular; diagnostics

The Toronto based company Safeguard Biosystems (SGBio) is developing a reusable platform for identifying bloodborne pathogenic bacteria. SGBio's unique molecular assay has the potential to replace the current standard of cell-culture based assays. Their approach offers a tremendous advantage in both reliability and efficiency of diagnosis. SGBio is collaborating with the Milstein Lab, at the University of Toronto, on the development of a Bioinformatics software platform and the construction of a diagnostic decision tree to incorporate into their device. The software will improve the effectiveness of their product by yielding a more accurate diagnosis as well as streamline the throughput of their product workflow. It will also help bring the product to market quicker with a reduced operating cost.

总部位于多伦多的SafeguardBiosystems（SGBio）公司正在开发一种可重复使用的平台，用于识别血源性致病菌。SGBio独特的分子检测有可能取代目前基于细胞培养的检测标准。他们的方法在诊断的可靠性和效率方面都具有巨大的优势。SGBio正在与多伦多大学的Milstein实验室合作，开发生物信息学软件平台，并构建诊断决策树以纳入其设备。该软件将通过产生更准确的诊断以及简化其产品工作流程的吞吐量来提高其产品的有效性。它还将有助于以更低的运营成本更快地将产品推向市场。